Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.960
-0.020 (-1.01%)
Dec 27, 2024, 4:00 PM EST - Market closed

Adagene Revenue

Adagene had revenue of $815.75K in the twelve months ending June 30, 2024, down -96.40% year-over-year. In the year 2023, Adagene had annual revenue of $18.11M with 94.90% growth.

Revenue (ttm)
$815.75K
Revenue Growth
-96.40%
P/S Ratio
105.80
Revenue / Employee
$4,688
Employees
174
Market Cap
86.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202318.11M8.82M94.90%
Dec 31, 20229.29M-882.53K-8.67%
Dec 31, 202110.18M9.47M1,351.71%
Dec 31, 2020700.91K220.91K46.02%
Dec 31, 2019480.00K-1.03M-68.24%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CytomX Therapeutics 126.62M
Assertio Holdings 125.76M
Theratechnologies 84.32M
Exagen 55.75M
Adlai Nortye 5.00M
Century Therapeutics 2.68M
Monogram Technologies 365.00K
Zentek 29.13K
Revenue Rankings

ADAG News

More News